Developments in the biosimilars market are expected to significantly boost the growth rate to 18%

Biosimilars Market 2022 – Opportunities and Strategies – Global Forecast to 2030

The Business Research Company Global Biosimilars Market Report 2022 – Global Market Size, Trends and Forecasts 2022-2030

LONDON, GREATER LONDON, UK, June 21, 2022 /EINPresswire.com/ — The biosimilars market is seeing robust research and development activity. These research and development activities have led to increasing success rates in clinical trials. According to the biosimilars market analysis, research and development is driven by biosimilars market leaders as they continuously strive to make inroads in the market in the form of new and effective drugs. For example, since October 2020, Spectrum Pharmaceuticals, a biopharmaceutical company specializing in novel and targeted oncology therapies, has been awaiting FDA approval for a biologics license application (BLA) for ROLONTIS, a novel colony-stimulating factor. long-acting granulocyte (G-CSF), an indication for the treatment of neutropenia in patients receiving myelosuppressive anticancer drugs.

The global biosimilars market size is expected to grow from $9.79 billion in 2020 to $22.21 billion in 2025 at a rate of 17.8%. The global biosimilars market size is then expected to grow at a CAGR of 17.5% from 2025 and reach $49.79 billion in 2030.

Learn more about the Global Biosimilars Market report
https://www.thebusinessresearchcompany.com/report/biosimilars-market

According to the biosimilars market overview, the increase in the number of cancer cases across the world has contributed to the growth of the market over the historical period. It is observed that the prevalence rate in oncology is highest among the elderly population. Cancer is the second leading cause of death, accounting for approximately 1 in 6 cancer deaths worldwide. According to the American Cancer Society, there are 1.8 million new cancer cases and 0.60 million deaths in the United States in 2020, or about 4,950 new cases and more than 1,600 deaths every day. About 70% of cancer deaths occur in low- and middle-income countries.

Key players covered in the global biosimilars industry are Amgen, Pfizer, Novartis AG, Viatris, Celltrion, Inc.

The global TBRC Biosimilars market report is segmented by Type into Monoclonal Antibodies, Insulin, Erythropoietin, Granulocyte Colony Stimulating Factor, Other Hormones, Others, by Application in Oncology, Chronic and Autoimmune Diseases, Hormone Deficiency growth, infectious diseases, other applications.

Biosimilars Market 2022 – By Type (Monoclonal Antibodies, Insulin, Erythropoietin, Granulocyte Colony Stimulating Factor, Other Hormone), By Application (Oncology, Chronic & Autoimmune Diseases, Growth Hormone Deficiency, Infectious Diseases), and By Region, Opportunities & Strategies – The Global Forecast to 2030 is part of a series of new reports from The Business Research Company that provide biosimilars market insights, forecast the size and growth of the global biosimilars market for the Market Overview, Biosimilars Market Segments, Geographies, Biosimilars Market Trends, Biosimilars Market Drivers, Restraints, Revenues, Key Competitor Profiles and Market Shares.

Request a Sample of the Global Biosimilars Market Report
https://www.thebusinessresearchcompany.com/sample.aspx?id=6175&type=smp

Not what you were looking for? Here is a list of similar reports from The Business Research Company:
Global Biosimilar Monoclonal Antibody Market Report 2022 – By Type (Synthetic Chemicals, Biopharmaceuticals), By Application (Chronic & Autoimmune Diseases, Oncology), By Compound (Infliximab, Rituximab, Abciximab, Trastuzumab, Adalimumab, Bevacizumab) ) – Market Size, Trends and Global Forecast 2022-2026
https://www.thebusinessresearchcompany.com/report/biosimilar-monoclonal-antibodies-global-market-report

Global Biosimilar Hormones Market Report 2022 – By Type (Teriparatide Biosimilars, Follitropin Alpha Biosimilars, Insulin Biosimilars, Somatropin Biosimilars), By Application (Research & Biotechnology, Diagnostics, Biocatalysts, Therapeutics), By Distribution Channel (Hospital & Retail Pharmacy, Online Pharmacy/ePharmacy, Specialty Clinics) – Global Market Size, Trends & Forecast 2022-2026
https://www.thebusinessresearchcompany.com/report/biosimilar-hormone-global-market-report

Global Filgrastim Biosimilars Market Report 2022 – By Application (Oncology, Chronic & Autoimmune Diseases, Blood Disorders, Growth Hormone Deficiency, Infectious Diseases), By Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Intrapharmaceutical Line), By Manufacturing Type (In-house Manufacturing, Contract Manufacturing Organization) – Global Market Size, Trends & Forecast 2022-2026
https://www.thebusinessresearchcompany.com/report/filgrastim-biosimilar-global-market-report

About the Business Research Company
The Business Research Company is a market research and intelligence firm that excels in business, market and consumer research. It has over 200 research professionals in its offices in India, the UK and the US, as well as a network of trained researchers globally. It has consultants specializing in a wide range of industries, including manufacturing, healthcare, financial services and technology.
Learn more about us at https://www.thebusinessresearchcompany.com/about-the-business-research-company.aspx

Call us now for personal assistance with your purchase:
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
The Business Research Society
Email: [email protected]
Follow us on LinkedIn: https://bit.ly/3b7850r
Follow us on Twitter: https://bit.ly/3b1rmjS
Check out our blog: http://blog.tbrc.info/

Olivier Guirdham
The Business Research Society
+44 20 7193 0708
[email protected]
Visit us on social media:
Facebook
Twitter
LinkedIn

Market Research Products, Services and Solutions for Your Business – TBRC